Show simple item record

Computed tomography enterography findings correlate with tissue inflammation, not fibrosis in resected small bowel Crohn's disease

dc.contributor.authorAdler, Jeremyen_US
dc.contributor.authorPunglia, Darashana R.en_US
dc.contributor.authorDillman, Jonathan R.en_US
dc.contributor.authorPolydorides, Alexandros D.en_US
dc.contributor.authorDave, Maneeshen_US
dc.contributor.authorAl‐hawary, Mahmoud M.en_US
dc.contributor.authorPlatt, Joel F.en_US
dc.contributor.authorMcKenna, Barbara J.en_US
dc.contributor.authorZimmermann, Ellen M.en_US
dc.date.accessioned2012-05-21T15:48:26Z
dc.date.available2013-07-01T14:33:05Zen_US
dc.date.issued2012-05en_US
dc.identifier.citationAdler, Jeremy; R. Punglia, Darashana; Dillman, Jonathan R.; Polydorides, Alexandros D.; Dave, Maneesh; Al‐hawary, Mahmoud M. ; Platt, Joel F.; McKenna, Barbara J.; Zimmermann, Ellen M. (2012). "Computed tomography enterography findings correlate with tissue inflammation, not fibrosis in resected small bowel Crohn's disease ." Inflammatory Bowel Diseases 18(5): 849-856. <http://hdl.handle.net/2027.42/91164>en_US
dc.identifier.issn1078-0998en_US
dc.identifier.issn1536-4844en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/91164
dc.description.abstractBackground: It has become commonplace to categorize small intestinal Crohn's disease (CD) as “active” vs. “inactive” or “inflammatory” vs. “fibrotic” based on computed tomography enterography (CTE) findings. Data on histologic correlates of CTE findings are lacking. We aimed to compare CTE findings with histology from surgically resected specimens. We tested the hypothesis that CTE findings can distinguish tissue inflammation from fibrosis. Methods: Patients who underwent CTE within 3 months before intestinal resection for CD were retrospectively studied. Radiologists blinded to history and histology scored findings on CTE. Pathologists blinded to history and imaging scored resected histology. We compared histology with CTE findings and radiologists assessment of whether the stricture was likely “active” or “inactive.” Results: In all, 22 patients met inclusion criteria. Inflammatory CTE findings correlated with histologic inflammation (rho = 0.52). Strictures believed to be “active” on CTE were more inflamed at histology ( P = 0.0002). Strictures lacking inflammatory findings on CTE or considered “inactive” were not associated with greater histologic fibrosis or significant histologic inflammation. Upstream dilation was associated with greater tissue fibrosis in univariate ( P = 0.014) but not in multivariate analysis ( P = 0.53). Overall, histologic fibrosis correlated best with histologic inflammation (rho = 0.52). Strictures on CTE with the most active disease activity also had the most fibrosis on histology. Conclusions: CTE findings of mesenteric hypervascularity, mucosal hyperenhancement, and mesenteric fat stranding predict tissue inflammation. However, small bowel stricture without CTE findings of inflammation does not predict the presence of tissue fibrosis. Therefore, caution should be used when using CTE criteria to predict the presence of scar tissue. (Inflamm Bowel Dis 2011;)en_US
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.subject.otherStrictureen_US
dc.subject.otherHistologyen_US
dc.subject.otherCT Enterographyen_US
dc.subject.otherCrohn's Diseaseen_US
dc.subject.otherFibrosisen_US
dc.titleComputed tomography enterography findings correlate with tissue inflammation, not fibrosis in resected small bowel Crohn's diseaseen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Radiology, Division of Abdominal Imaging, University of Michigan Health System, Ann Arbor, Michiganen_US
dc.contributor.affiliationumUniversity of Michigan, 1150 W. Medical Center Dr., A520B MSRB I, Box 5658, Ann Arbor MI 48109en_US
dc.contributor.affiliationumDivision of Gastroenterology, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDivision of Pediatric Gastroenterology, Department of Pediatrics and Communicable Diseases, University of Michigan Health System, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDepartment of Internal Medicine, University of Michigan Health System, Ann Arbor, Michiganen_US
dc.contributor.affiliationumSection of Pediatric Radiology, Department of Radiology, University of Michigan Health System, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDepartment of Pathology, University of Michigan Health System, Ann Arbor, Michiganen_US
dc.contributor.affiliationotherDepartment of Internal Medicine, Wayne State University, Detroit, Michiganen_US
dc.identifier.pmid21710535en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/91164/1/21801_ftp.pdf
dc.identifier.doi10.1002/ibd.21801en_US
dc.identifier.sourceInflammatory Bowel Diseasesen_US
dc.identifier.citedreferenceLiu YB, Liang CH, Zhang ZL, et al. Crohn disease of small bowel: multidetector row CT with CT enteroclysis, dynamic contrast enhancement, CT angiography, and 3D imaging. Abdom Imaging. 2006; 31: 668 – 674.en_US
dc.identifier.citedreferenceZimmermann EM, Lund PK. Fibrogenesis in inflammatory bowel disease. In: Kirsner J, ed. Inflammatory Bowel Disease. Philadelphia: W.B. Saunders; 2003.en_US
dc.identifier.citedreferencePucilowska JB, Williams KL, Lund PK. Fibrogenesis. IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models. Am J Physiol. 2000; 279: G653 – 659.en_US
dc.identifier.citedreferenceKumagai S, Kawano S, Atsumi T, et al. Vertebral fracture and bone mineral density in women receiving high dose glucocorticoids for treatment of autoimmune diseases. J Rheumatol. 2005; 32: 863 – 869.en_US
dc.identifier.citedreferenceBollet AJ, Black R, Bunim JJ. Major undesirable side‐effects resulting from prednisolone and prednisone. JAMA. 1955; 158: 459 – 463.en_US
dc.identifier.citedreferenceWhitworth JA. Adrenocorticotrophin and steroid‐induced hypertension in humans. Kidney Int. 1992; 37: S34 – 37.en_US
dc.identifier.citedreferenceSaag KG, Koehnke R, Caldwell JR, et al. Low dose long‐term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med. 1994; 96: 115 – 123.en_US
dc.identifier.citedreferenceBrenner DJ, Hall EJ. Computed tomography—an increasing source of radiation exposure. N Engl J Med. 2007; 357: 2277 – 2284.en_US
dc.identifier.citedreferenceYamamoto T, Allan RN, Keighley MR. Risk factors for intra‐abdominal sepsis after surgery in Crohn's disease. Dis Colon Rectum. 2000; 43: 1141 – 1145.en_US
dc.identifier.citedreferenceAlves A, Panis Y, Bouhnik Y, et al. Risk factors for intra‐abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum. 2007; 50: 331 – 336.en_US
dc.identifier.citedreferenceGervais DA, Hahn PF, O'Neill MJ, et al. Percutaneous abscess drainage in Crohn disease: technical success and short‐ and long‐term outcomes during 14 years. Radiology. 2002; 222: 645 – 651.en_US
dc.identifier.citedreferencePost S, Betzler M, von Ditfurth B, et al. Risks of intestinal anastomoses in Crohn's disease. Ann Surg. 1991; 213: 37 – 42.en_US
dc.identifier.citedreferenceSteffes C, Fromm D. Is preoperative parenteral nutrition necessary for patients with predominantly ileal Crohn's disease? Arch Surg. 1992; 127: 1210 – 1212.en_US
dc.identifier.citedreferenceBodily KD, Fletcher JG, Solem CA, et al. Crohn disease: mural attenuation and thickness at contrast‐enhanced CT enterography—correlation with endoscopic and histologic findings of inflammation. Radiology. 2006; 238: 505 – 516.en_US
dc.identifier.citedreferenceTaylor SA, Punwani S, Rodriguez‐Justo M, et al. Mural Crohn disease: correlation of dynamic contrast‐enhanced MR imaging findings with angiogenesis and inflammation at histologic examination—pilot study. Radiology. 2009; 251: 369 – 379.en_US
dc.identifier.citedreferenceAro P, Ronkainen J, Talley NJ, et al. Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study. Gut. 2005; 54: 1377 – 1383.en_US
dc.identifier.citedreferenceJoo JS, Agachan F, Wexner SD. Laparoscopic surgery for lower gastrointestinal fistulas. Surg Endosc. 1997; 11: 116 – 118.en_US
dc.identifier.citedreferenceYoung S, Smith IS, O'Connor J, et al. Results of surgery for Crohn's disease in the Glasgow region, 1961–70. Br J Surg. 1975; 62: 528 – 534.en_US
dc.identifier.citedreferenceLazarev M, Ullman T, Schraut WH, et al. Small bowel resection rates in Crohn's disease and the indication for surgery over time: experience from a large tertiary care center. Inflamm Bowel Dis. 2010; 16: 830 – 835.en_US
dc.identifier.citedreferenceSoyer P, Boudiaf M, Sirol M, et al. Suspected anastomotic recurrence of Crohn disease after ileocolic resection: evaluation with CT enteroclysis. Radiology. 2010; 254: 755 – 764.en_US
dc.identifier.citedreferenceLeighton JA, Shen B, Baron TH, et al. ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. Gastrointest Endosc. 2006; 63: 558 – 565.en_US
dc.identifier.citedreferencevon Ahsen N, Armstrong VW, Behrens C, et al. Association of inosine triphosphatase 94C>A and thiopurine S‐methyltransferase deficiency with adverse events and study drop‐outs under azathioprine therapy in a prospective Crohn disease study. Clin Chem. 2005; 51: 2282 – 2288.en_US
dc.identifier.citedreferenceHiggins LM, McDonald SA, Whittle N, et al. Regulation of T cell activation in vitro and in vivo by targeting the OX40‐OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40‐IgG fusion protein, but not with an OX40 ligand‐IgG fusion protein. J Immunol. 1999; 162: 486 – 493.en_US
dc.identifier.citedreferenceSolem CA, Loftus EV Jr, Tremaine WJ, et al. Correlation of C‐reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis. 2005; 11: 707 – 712.en_US
dc.identifier.citedreferenceLahat A, Chowers Y. The patient with recurrent (sub) obstruction due to Crohn's disease. Best Pract Res. 2007; 21: 427 – 444.en_US
dc.identifier.citedreferenceMaconi G, Carsana L, Fociani P, et al. Small bowel stenosis in Crohn's disease: clinical, biochemical and ultrasonographic evaluation of histological features. Aliment Pharmacol Ther. 2003; 18: 749 – 756.en_US
dc.identifier.citedreferenceTheiss AL, Fuller CR, Simmons JG, et al. Growth hormone reduces the severity of fibrosis associated with chronic intestinal inflammation. Gastroenterology. 2005; 129: 204 – 219.en_US
dc.identifier.citedreferenceChiorean MV, Sandrasegaran K, Saxena R, et al. Correlation of CT enteroclysis with surgical pathology in Crohn's disease. Am J Gastroenterol. 2007; 102: 2541 – 2550.en_US
dc.identifier.citedreferenceEbinger M, Leidl R, Thomas S, et al. Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital. J Gastroenterol Hepatol. 2004; 19: 192 – 199.en_US
dc.identifier.citedreferenceKonig HH, Ulshofer A, Gregor M, et al. Validation of the EuroQol questionnaire in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2002; 14: 1205 – 1215.en_US
dc.identifier.citedreferenceSchmid RM, Adler G, Liptay S. Activation of NFkappaB in inflammatory bowel disease. Gut. 1998; 43: 587 – 588.en_US
dc.identifier.citedreferenceZappa M, Stefanescu C, Cazals‐Hatem D, et al. Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn's disease? A retrospective comparison with surgical pathologic analysis. Inflamm Bowel Dis. 2011; 17: 984 – 993.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.